Biomx Other Liab vs Common Stock Total Equity Analysis

PHGE Stock

USD 0.55 0.01 1.85%

Biomx financial indicator trend analysis is way more than just evaluating Biomx Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biomx Inc is a good investment. Please check the relationship between Biomx Other Liab and its Common Stock Total Equity accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Biomx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Other Liab vs Common Stock Total Equity

Other Liab vs Common Stock Total Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biomx Inc Other Liab account and Common Stock Total Equity. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Biomx's Other Liab and Common Stock Total Equity is -0.12. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Common Stock Total Equity in the same time period over historical financial statements of Biomx Inc, assuming nothing else is changed. The correlation between historical values of Biomx's Other Liab and Common Stock Total Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Biomx Inc are associated (or correlated) with its Common Stock Total Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Total Equity has no effect on the direction of Other Liab i.e., Biomx's Other Liab and Common Stock Total Equity go up and down completely randomly.

Correlation Coefficient

-0.12

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Other Liab

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Most indicators from Biomx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biomx Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Biomx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

The current year's Issuance Of Capital Stock is expected to grow to about 9.2 M, whereas Selling General Administrative is forecasted to decline to about 7.4 M.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	35.5M	27.2M	26.8M	22.4M
Research Development	22.7M	16.2M	19.0M	14.7M

Total Operating Expenses Research Development

Biomx fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Net Invested Capital
Total Assets		0.76	0.91	0.88	0.78	0.17	0.86	-0.76	-0.79	0.87	0.87	0.63	-0.25	-0.8	0.9	-0.17	0.17	-0.94	0.38	0.63	0.89	0.83	0.94	0.69	-0.83	0.79
Short Long Term Debt Total	0.76		0.81	0.94	0.35	0.41	0.52	-0.59	-0.89	0.78	0.85	0.6	-0.41	-0.83	0.59	0.13	-0.16	-0.68	-0.2	0.73	0.8	0.78	0.91	0.78	-0.91	0.42
Other Current Liab	0.91	0.81		0.91	0.63	0.07	0.65	-0.82	-0.76	0.96	0.93	0.6	-0.28	-0.73	0.8	-0.25	-0.02	-0.77	0.08	0.64	0.8	0.88	0.87	0.71	-0.84	0.62
Total Current Liabilities	0.88	0.94	0.91		0.47	0.39	0.64	-0.64	-0.92	0.89	0.87	0.72	-0.35	-0.82	0.68	0.1	-0.1	-0.77	-0.05	0.79	0.88	0.84	0.97	0.84	-0.97	0.5
Total Stockholder Equity	0.78	0.35	0.63	0.47		-0.4	0.73	-0.84	-0.26	0.64	0.68	0.04	-0.03	-0.41	0.96	-0.6	0.36	-0.79	0.73	0.0	0.52	0.64	0.58	0.09	-0.4	0.93
Other Liab	0.17	0.41	0.07	0.39	-0.4		0.18	0.4	-0.66	0.04	0.02	0.76	-0.18	-0.44	-0.21	0.89	-0.12	-0.19	-0.34	0.77	0.43	0.05	0.41	0.73	-0.48	-0.28
Net Tangible Assets	0.86	0.52	0.65	0.64	0.73	0.18		-0.5	-0.67	0.57	0.59	0.56	-0.47	-0.82	0.79	-0.15	0.13	-0.79	0.62	0.49	0.87	0.53	0.77	0.54	-0.58	0.87
Net Debt	-0.76	-0.59	-0.82	-0.64	-0.84	0.4	-0.5		0.38	-0.86	-0.9	-0.07	0.13	0.44	-0.9	0.57	-0.04	0.7	-0.26	-0.13	-0.54	-0.87	-0.64	-0.23	0.59	-0.74
Retained Earnings	-0.79	-0.89	-0.76	-0.92	-0.26	-0.66	-0.67	0.38		-0.72	-0.72	-0.86	0.49	0.9	-0.5	-0.37	0.2	0.69	0.12	-0.92	-0.93	-0.7	-0.92	-0.95	0.93	-0.38
Accounts Payable	0.87	0.78	0.96	0.89	0.64	0.04	0.57	-0.86	-0.72		0.94	0.53	-0.24	-0.64	0.79	-0.18	-0.12	-0.75	0.03	0.57	0.78	0.96	0.84	0.65	-0.87	0.57
Cash	0.87	0.85	0.93	0.87	0.68	0.02	0.59	-0.9	-0.72	0.94		0.43	-0.29	-0.71	0.84	-0.24	-0.06	-0.81	0.05	0.52	0.77	0.95	0.85	0.6	-0.83	0.65
Non Current Assets Total	0.63	0.6	0.6	0.72	0.04	0.76	0.56	-0.07	-0.86	0.53	0.43		-0.3	-0.71	0.24	0.47	-0.06	-0.53	-0.1	0.98	0.76	0.42	0.71	0.96	-0.73	0.15
Non Currrent Assets Other	-0.25	-0.41	-0.28	-0.35	-0.03	-0.18	-0.47	0.13	0.49	-0.24	-0.29	-0.3		0.71	-0.14	-0.05	0.72	0.01	0.15	-0.36	-0.6	-0.23	-0.33	-0.37	0.33	-0.34
Other Assets	-0.8	-0.83	-0.73	-0.82	-0.41	-0.44	-0.82	0.44	0.9	-0.64	-0.71	-0.71	0.71		-0.6	-0.08	0.21	0.67	-0.09	-0.76	-0.95	-0.6	-0.86	-0.8	0.77	-0.62
Cash And Short Term Investments	0.9	0.59	0.8	0.68	0.96	-0.21	0.79	-0.9	-0.5	0.79	0.84	0.24	-0.14	-0.6		-0.49	0.27	-0.89	0.57	0.24	0.69	0.79	0.77	0.33	-0.61	0.92
Net Receivables	-0.17	0.13	-0.25	0.1	-0.6	0.89	-0.15	0.57	-0.37	-0.18	-0.24	0.47	-0.05	-0.08	-0.49		-0.27	0.12	-0.47	0.48	0.13	-0.11	0.09	0.42	-0.26	-0.55
Common Stock Total Equity	0.17	-0.16	-0.02	-0.1	0.36	-0.12	0.13	-0.04	0.2	-0.12	-0.06	-0.06	0.72	0.21	0.27	-0.27		-0.41	0.61	-0.14	-0.2	-0.16	0.03	-0.13	0.19	0.21
Common Stock Shares Outstanding	-0.94	-0.68	-0.77	-0.77	-0.79	-0.19	-0.79	0.7	0.69	-0.75	-0.81	-0.53	0.01	0.67	-0.89	0.12	-0.41		-0.47	-0.52	-0.76	-0.75	-0.87	-0.59	0.73	-0.75
Short Term Investments	0.38	-0.2	0.08	-0.05	0.73	-0.34	0.62	-0.26	0.12	0.03	0.05	-0.1	0.15	-0.09	0.57	-0.47	0.61	-0.47		-0.25	0.16	0.01	0.15	-0.22	0.12	0.72
Non Current Liabilities Total	0.63	0.73	0.64	0.79	0.0	0.77	0.49	-0.13	-0.92	0.57	0.52	0.98	-0.36	-0.76	0.24	0.48	-0.14	-0.52	-0.25		0.77	0.48	0.75	0.99	-0.79	0.11
Capital Surpluse	0.89	0.8	0.8	0.88	0.52	0.43	0.87	-0.54	-0.93	0.78	0.77	0.76	-0.6	-0.95	0.69	0.13	-0.2	-0.76	0.16	0.77		0.75	0.92	0.82	-0.87	0.66
Other Current Assets	0.83	0.78	0.88	0.84	0.64	0.05	0.53	-0.87	-0.7	0.96	0.95	0.42	-0.23	-0.6	0.79	-0.11	-0.16	-0.75	0.01	0.48	0.75		0.82	0.57	-0.86	0.56
Other Stockholder Equity	0.94	0.91	0.87	0.97	0.58	0.41	0.77	-0.64	-0.92	0.84	0.85	0.71	-0.33	-0.86	0.77	0.09	0.03	-0.87	0.15	0.75	0.92	0.82		0.81	-0.94	0.63
Total Liab	0.69	0.78	0.71	0.84	0.09	0.73	0.54	-0.23	-0.95	0.65	0.6	0.96	-0.37	-0.8	0.33	0.42	-0.13	-0.59	-0.22	0.99	0.82	0.57	0.81		-0.84	0.19
Deferred Long Term Liab	-0.83	-0.91	-0.84	-0.97	-0.4	-0.48	-0.58	0.59	0.93	-0.87	-0.83	-0.73	0.33	0.77	-0.61	-0.26	0.19	0.73	0.12	-0.79	-0.87	-0.86	-0.94	-0.84		-0.4
Net Invested Capital	0.79	0.42	0.62	0.5	0.93	-0.28	0.87	-0.74	-0.38	0.57	0.65	0.15	-0.34	-0.62	0.92	-0.55	0.21	-0.75	0.72	0.11	0.66	0.56	0.63	0.19	-0.4

Click cells to compare fundamentals

Biomx Account Relationship Matchups

Biomx fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Short Long Term Debt Total	1.2M	5.9M	20.0M	19.4M	15.1M	9.8M
Other Liab	585K	701K	215K	2.2M	2.5M	2.6M
Net Tangible Assets	42.8M	84.5M	57.5M	46.0M	52.9M	53.3M
Retained Earnings	(42.2M)	(72.3M)	(108.5M)	(136.8M)	(163.0M)	(154.8M)
Non Currrent Assets Other	70.9M	(70.9M)	7.5M	(28.9M)	(26.0M)	(24.7M)
Net Receivables	50K	276K	(108K)	567K	574K	602.7K
Common Stock Shares Outstanding	5.6M	2.3M	2.6M	3.0M	5.1M	3.4M
Net Invested Capital	84.5M	57.5M	61.9M	35.9M	14.3M	13.6M
Net Working Capital	78.3M	53.5M	55.6M	28.9M	6.5M	6.1M
Property Plant Equipment	887K	3.0M	6.7M	9.8M	11.3M	11.9M
Capital Lease Obligations	1.2M	5.9M	5.6M	4.5M	3.9M	3.9M
Property Plant And Equipment Gross	3.0M	6.7M	9.8M	8.7M	10.9M	7.3M
Non Current Liabilities Other	585K	701K	215K	188K	155K	147.3K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Biomx Inc is a strong investment it is important to analyze Biomx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biomx's future performance. For an informed investment choice regarding Biomx Stock, refer to the following important reports:

How To Invest In Biomx

Details

Is Biomx Stock a good investment?

Details

What is Biomx's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Biomx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomx. If investors know Biomx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.26)

Return On Assets

(0.33)

Return On Equity

(1.21)

The market value of Biomx Inc is measured differently than its book value, which is the value of Biomx that is recorded on the company's balance sheet. Investors also form their own opinion of Biomx's value that differs from its market value or its book value, called intrinsic value, which is Biomx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomx's market value can be influenced by many factors that don't directly affect Biomx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biomx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biomx Other Liab vs Common Stock Total Equity Analysis

Other Liab vs Common Stock Total Equity

Other Liab vs Common Stock Total Equity Correlation Analysis

Correlation Coefficient

Other Liab

Common Stock Total Equity

Biomx fundamental ratios Correlations

Biomx Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biomx fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.99	Non Current Liabilities Total
Non Current Liabilities Total	+ 0.98	Non Current Assets Total
Other Stockholder Equity	+ 0.97	Total Current Liabilities
Accounts Payable	+ 0.96	Other Current Liab
Cash And Short Term Investments	+ 0.96	Total Stockholder Equity
Other Current Assets	+ 0.96	Accounts Payable

Deferred Long Term Liab	- 0.97	Total Current Liabilities
Capital Surpluse	- 0.95	Other Assets
Total Liab	- 0.95	Retained Earnings
Deferred Long Term Liab	- 0.94	Other Stockholder Equity
Common Stock Shares Outstanding	- 0.94	Total Assets
Capital Surpluse	- 0.93	Retained Earnings